It has been suggested that trimethylamine N‐oxide (TMAO) is associated with increased risk
of diabetes and cardiovascular disease (CVD) morbidity and mortality. However, it is not …

ABSTRACT Background Trimethylamine-N-oxide (TMAO) is a gut microbiota–derived
metabolite produced from dietary nutrients. Many studies have discovered that circulating …

The gut microbial metabolite trimethylamine N-oxide (TMAO) is increasingly regarded as a
novel risk factor for cardiovascular events and mortality. However, little is known about the …

Elevated circulating concentrations of the gut bacteria choline metabolite trimethylamine N‐
oxide (TMAO) were found in patients with type 2 diabetes mellitus (T2DM). However …

The gut microbiota–derived metabolite trimethylamine N-oxide (TMAO) has been regarded
as one of the potent risk factors of cardiovascular events and diabetes. However, its …

ABSTRACT Background Trimethylamine N-oxide (TMAO), a compound derived from diet
and metabolism by the gut microbiome, has been associated with several chronic diseases …

Aims Gut microbiota-derived metabolite trimethylamine-N-oxide (TMAO) is emerging as a
new potentially important cause of increased cardiovascular risk. The purpose of this meta …

ABSTRACT Background Trimethylamine N-oxide (TMAO), a diet-derived, gut microbial-host
cometabolite, has been linked to cardiometabolic diseases. However, the relations remain …

Trimethylamine-N-oxide (TMAO) is the main diet-induced metabolite produced by the gut
microbiota, and it is mainly eliminated through renal excretion. TMAO has been correlated …

Aims Several epidemiological studies have examined the association between
trimethylamine N-Oxide (TMAO) and stroke risk; however, the results are still inconclusive …